The Effects of Estrogen, Progesterone, and C-Erbb Receptor States on 18f-Fdg Uptake of Primary Breast Cancer Lesions

dc.contributor.author Mavi, Ayşe
dc.contributor.author Çermik, Tevfik F.
dc.contributor.author Urhan, Muammer
dc.contributor.author Püskülcü, Halis
dc.contributor.author Basu, Sandip
dc.contributor.author Yu, Jian Q.
dc.contributor.author Zhuang, Hongming
dc.contributor.author Czerniecki, Brian
dc.contributor.author Alavi, Abass
dc.coverage.doi 10.2967/jnumed.106.037440
dc.date.accessioned 2016-08-11T12:13:06Z
dc.date.available 2016-08-11T12:13:06Z
dc.date.issued 2007
dc.description.abstract The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before undergoing partial or total mastectomy, 213 patients with newly diagnosed breast cancer underwent 18F-FDG PET (5.2 MBq/kg of body weight). The maximum standardized uptake value (SUV) of the primary lesion was measured in each patient. Standard immunohistochemistry was performed on a surgical specimen of the cancer lesion to characterize the receptor state of the tumor cells. Pearson χ2 tests were performed on the cross-tables of different receptor states to test any association that may exist among ER, PR, and C-erbB-2R. Maximum SUV measurements for different receptor states were compared using factorial ANOVA in a completely random design. Results: After exclusion of certain lesions, 118 lesions were analyzed for this study. The mean maximum SUVs of ER-positive and ER-negative lesions were 3.03 ± 0.26 and 5.64 ± 0.75, whereas those of PR were 3.24 ± 0.29 and 4.89 ± 0.67, respectively, and those of C-erbB-2R were 4.64 ± 0.70 and 3.70 ± 0.35, respectively, χ2 tests for ER and PR showed that if one is positive then the other tends to be positive as well (χ2 = 71.054, P < 0.01). For ER and C-erbB-2R states, if ER is positive, C-erbB-2R will more likely be negative (χ2 = 13.026, P < 0.01). No relationship was detected between PR and C-erbB-2R states (χ2 = 3.695, P > 0.05). ANOVAs showed that PR state alone (F = 0.095, P > 0.05) and C-erbB-2R state alone (F = 0.097, P > 0.05) had no effect on 18F-FDG uptake but ER state alone had an effect (F = 9.126, P < 0.01). ER and PR being together had no additional effect on 18F-FDG uptake. Our study also demonstrated that interactions exist between ER and C-erbB-2R state and between PR and C-erbB-2R state. Conclusion: SUV measurements may provide valuable information about the state of ER, PR, and C-erbB-2R and the associated glucose metabolism as measured by 18F-FDG uptake of the primary breast cancer lesions. Such an association may be of importance to treatment planning and outcome in these patients. en_US
dc.description.sponsorship Public Health Services research grant M01-RR00040 en_US
dc.identifier.citation Mavi, A., Çermik, T. F., Urhan, M., Püskülcü, H., Basu, S., Yu, J. Q., Zhuang, H., Czerniecki, B., and Alavi, A. (2007). The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. Journal of Nuclear Medicine, 48(8), 1266-1272. doi:10.2967/jnumed.106.037440 en_US
dc.identifier.doi 10.2967/jnumed.106.037440
dc.identifier.doi 10.2967/jnumed.106.037440 en_US
dc.identifier.issn 0161-5505
dc.identifier.scopus 2-s2.0-34547773618
dc.identifier.uri http://doi.org/10.2967/jnumed.106.037440
dc.identifier.uri https://hdl.handle.net/11147/2087
dc.language.iso en en_US
dc.publisher Society of Nuclear Medicine and Molecular Imaging en_US
dc.relation.ispartof Journal of Nuclear Medicine en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Breast cancer en_US
dc.subject Estrogen en_US
dc.subject Interactions between receptors en_US
dc.subject Progesterone en_US
dc.subject Correlation analysis en_US
dc.title The Effects of Estrogen, Progesterone, and C-Erbb Receptor States on 18f-Fdg Uptake of Primary Breast Cancer Lesions en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.institutional Püskülcü, Halis
gdc.bip.impulseclass C4
gdc.bip.influenceclass C4
gdc.bip.popularityclass C4
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology. Computer Engineering en_US
gdc.description.endpage 1272 en_US
gdc.description.issue 8 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.startpage 1266 en_US
gdc.description.volume 48 en_US
gdc.description.wosquality Q1
gdc.identifier.openalex W2147837737
gdc.identifier.pmid 17631558
gdc.identifier.wos WOS:000248584300023
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.accesstype BRONZE
gdc.oaire.diamondjournal false
gdc.oaire.impulse 13.0
gdc.oaire.influence 6.9952564E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Adult
gdc.oaire.keywords Receptor, ErbB-2
gdc.oaire.keywords Correlation analysis
gdc.oaire.keywords Breast Neoplasms
gdc.oaire.keywords Middle Aged
gdc.oaire.keywords Estrogen
gdc.oaire.keywords Breast cancer
gdc.oaire.keywords Receptors, Estrogen
gdc.oaire.keywords Fluorodeoxyglucose F18
gdc.oaire.keywords Positron-Emission Tomography
gdc.oaire.keywords Interactions between receptors
gdc.oaire.keywords Humans
gdc.oaire.keywords Female
gdc.oaire.keywords Radiopharmaceuticals
gdc.oaire.keywords Receptors, Progesterone
gdc.oaire.keywords Progesterone
gdc.oaire.keywords Aged
gdc.oaire.popularity 8.159282E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.openalex.collaboration International
gdc.openalex.fwci 3.13615471
gdc.openalex.normalizedpercentile 0.9
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 74
gdc.plumx.crossrefcites 45
gdc.plumx.mendeley 35
gdc.plumx.pubmedcites 32
gdc.plumx.scopuscites 75
gdc.scopus.citedcount 75
gdc.wos.citedcount 72
local.message.claim 2022-06-06T14:28:42.078+0300 *
local.message.claim |rp02964 *
local.message.claim |submit_approve *
local.message.claim |dc_contributor_author *
local.message.claim |None *
relation.isAuthorOfPublication.latestForDiscovery f3844554-c555-4f40-8a31-c2b1f5f2d3e6
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4014-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
2087.pdf
Size:
689.74 KB
Format:
Adobe Portable Document Format
Description:
Makale

License bundle

Now showing 1 - 1 of 1
Loading...
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: